Kennedy KA, et al. - An evaluation was performed by the authors with regard to the effects of bevacizumab on nonophthalmologic outcomes. Bevacizumab vs laser therapy did not exhibit adverse effects on medical or neurodevelopmental outcomes for retinopathy of prematurity.